← Research library

Actovegin in the management of patients after ischemic stroke: A systematic review.

Review of earlier studies · 2022

What was studied
Five controlled studies after ischemic stroke; one randomized trial and four observational studies
Main finding
The review found uncertain benefit and no consistent evidence of improved survival, disability, daily activities or quality of life. It flagged potential harm and called for better trials.

Study data at a glance

Participants or experimental model
Five controlled studies after ischemic stroke; one randomized trial and four observational studies
Reported results
The review found uncertain benefit and no consistent evidence of improved survival, disability, daily activities or quality of life. It flagged potential harm and called for better trials.
Study limitations and source details

Study limitations

  • Heterogeneous evidence precluded meta-analysis. This review includes ARTEMIDA and is not an independent additional trial.

Source details

Journal publication

Indexed citation and abstract checked; full methods and risk-of-bias appraisal remain incomplete.

Sources checked

Citation

ReviewEnglish abstract

la Fleur P, Baizhaxynova A, Reynen E, Kaunelis D, Galiyeva D. Actovegin in the management of patients after ischemic stroke: A systematic review. PloS one

Study source ↗ · DOI 10.1371/journal.pone.0270497 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards